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ABSTRACT
Annually over 3 million people suffer from intervertebral disc (IVD) herniation
(IVDH)1 and approximately 500,000 discectomies are performed in the United States
alone. Within one-year post-operation, up to 15% of patients must undergo a second
discectomy or spinal reconstruction due to re-herniation2. One potential method to
overcome limitations associated with discectomies is to develop tissue engineered
constructs to augment the surgical procedure. Previously two novel scaffolds have been
created by our lab: an annulus fibrosus repair patch (AFRP) and acellular bovine nucleus
pulposus (ABNP); however, these constructs require extensive testing before
implementation in humans. Therefore, the purpose of the work herein was to create an ex
vivo IVDH bovine organ culture that mimics key features of the herniated IVD
microenvironment that can be used to assess the efficacy of scaffolds developed for IVDH
repair and regeneration.
Fresh oxtails were acquired from a local abattoir and bovine IVDs (bIVDs) were
isolated and separated into three groups. The Control group did not undergo a discectomy
and were without the presence of additional inflammatory cytokines. The Injury group
underwent a discectomy, using a 6mm biopsy and surgical rongeurs, and were cultured in
the presence of 250 𝜌g/mL of both IL-1𝛽 and TNF-𝛼. Lastly, the Repair group underwent
the same discectomy, but was repaired two days later with the AFRP and ABNP seeded
with human amniotic mesenchymal stromal cells (hAMSCs).
Results showed that all three groups maintained cell viability out to 30 days in all
key regions of the bIVD. Furthermore, histological analysis showed that the Injury group
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showed trends of degeneration relative to the Control group such as decreased staining
intensity of glycosaminoglycans (GAGs) and distortion of the annulus fibrosus (AF).
Alternatively, the Repair group showed each scaffold was histologically like its native
counterparts and showed an overall less degenerative state than the Injury. In summary, a
viable free swelling of bIVDs was created establishing histological degenerative hallmarks
at 30 days while allowing for current tissue engineered scaffolds evaluations.
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CHAPTER ONE
LITERATURE REVIEW

I. Physiology and Anatomy of the IVD
The intervertebral discs (IVDs) are the soft tissue between the vertebral bodies and
act as the primary support structure for the human spine. The IVDs are separated into
various classifications based on their location: cervical, thoracic, lumbar, and sacrum.
There are 6 discs in the cervical region, 12 in the thoracic region, 5 in the lumbar, and 1
resides in the sacrum before the coccyx.3 Throughout each day, the IVDs are subjected to
various loading regimes yet must remain flexible in order not only to support the spine but
also to allow for mobility. For example, the mechanical loading of the IVD has been studied
in various body positions such as laying down, sitting, climbing stairs, jogging, and
lifting/twisting and experiences intradiscal pressures of 0.1-0.2 MPa, 0.46 MPa, 0.5-0.7
MPa, 0.35-0.95 MPa, and greater than 2 MPa for each of these activities respectively.4 The
IVD can withstand these forces by not only resisting the axial load, but its soft tissue
composition allows for the flexion/extension, lateral bending, and rotational forces5–13
similar to a shock absorber. The IVD accomplishes this due to its unique structure which
can be simply defined by three tissues: the annulus fibrosus (AF), the nucleus pulposus
(NP), and the cartilaginous endplate (CEP).
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interlamellar septae.19 The AF also contains about 2% elastin which has been shown to
play a key role in its recoil properties.19 Ultimately, this complex stacking of collagen fibers
allows for the AF to resist tensile ‘hoop’ or circumferential resistance allowing for the AF
to counteract the pressure of the NP.17
The AF can be subdivided into two regions namely the outer AF (OAF) and inner
AF (IAF). These regions varying in composition as the OAF is high in type I collagen but
slowly transitions to a mixture of type I and II collagen as it approaches the NP, which is
defined as the IAF or transition region.5,6,18,20 These regions contain fibroblast-like cells
(~9,000 cells/mm3),18 formed during embryogenesis from the mesenchyme.2,3,9,18

I.2 Nucleus Pulposus
The NP is the gelatinous core of the IVD granting the discs capability to withstand
substantial axial loads.5 The NP is rich in PGs and glycosaminoglycans (GAGs), most
prevalently by aggrecan, which is usually 30 chains of sulfated GAGs. These sulfated
chains lead to a net negative charge within the NP, resulting in cation attraction, and
subsequently, Water uptake in the region. This hyper hydrated state develops an osmotic
swelling pressure is created that allows for the IVD to resist gravity and other loads.10,16,18,20
Through this an osmotic pressure is created that allows for the IVD to resist gravity and
other loads. In addition to the presence of GAGs, the NP is rich in type II collagen with a
result GAG:HYP ratio of 27:1.18
The mature NP has a low cell density (~3,000 cells/mm3) of chondrocyte-like cells
which must survive a very hypoxic environment (1% O2).18 However, in youth the NP also
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contains cells known as notochordal cells which start to disappear with maturity.9,18 These
cells form during embryogenesis much like the AF, but from the notochord, not the
mesenchyme.3,18,19

I.3 Cartilaginous Endplate
The CEP is the thin layers of hyaline cartilage found above and below the AF/NP
securing the IVD between the vertebral bodies of the spine.16 The CEP is rich in type II
collagen and PGs as well, but in 2:1 GAG:HYP ratio synthesized from chondrocytes.18 In
addition to anchoring the IVD, the CEP also serves as the nutrient highway for the IVD.6
The CEP is 0.6mm thick serving to resist the osmotic pressure created by the IVD through
its dense 3D type II collagen architecture which anchors the CEP to a layer of perforated
cortical bone known as the boney endplate (BEP).17

II. Pathology of the IVD
Although the IVD has uniquely evolved to withstand the harsh environment and
severe mechanical loading, it is subject to a progressive degradation known as IVD
degeneration (IVDD). Low back pain (LBP) is often correlated to IVDD with symptomatic
IVDD contributing ~40% of all LBP cases.6,10,21–24 LBP is the second most common
complaint heard by physicians in the United States of America, only surpassed by the
common cold.11,25 Clinically, LBP is classified in two ways: 1) specific LBP, which is due
to an obvious cause such as fracture, infection, or tumor and 2) non-specific LBP, which
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is due to an unknown cause.26 Ultimately these types, will affect up to 80% of adults and
costs the United States approximately $90-100 billion annually.8,12,27,28 Globally, LBP is
the leading cause of disability worldwide.10,12 Some manifestations of IVDD are IVD
herniations (IVDH), annular fissures, Schmorl’s nodes, and total IVD degeneration.

II.1 Risk Factors and Causes of IVD
Degenerative changes and pathology of the IVD are complex and interconnected.
IVDD is induced by a variety of factors such as pathologic loading, mechanical damage,
biologic remodeling, response to injury, inflammation, or a combination of any or all of
these.22,29,30 Furthermore, influencing factors such as gender, body habitus, age, genetic
factors, occupation, environmental factors, and even other disease states such as diabetes
have been shown to increase the risk for the onset of IVDD.10,21,22,25,31,32 Onset of IVDD
can sometimes be attributed to a traumatic event such as a car accident which leads to cell
apoptosis.12 However, the disease pathogenesis is commonly unknown for most patients.
As medical research continues to study the source or root cause of IVDD it has become
hypothesized that there may not be a root cause due to the multifactorial influencers already
discovered.
Although the root cause for IVDD may not be identified, there are some known
factors that have been attributed to the subsequent degeneration. It has been suggested that
the first major alteration that allows for the IVD to degrade is the loss of notochordal cells10
which stimulate the collagen and GAG production in the NP as well as help prevent
apoptosis of the chondrocyte-like cells in the NP.5,18 Another distinct transition that is
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known to cause IVDD is the progressive calcification of the CEPs due to a hypertrophic
conversion of the chondrocytes to synthesize type X collagen. As the CEPs calcify the
nutrient transport and export of the avascular IVD is drastically impaired6 thought to result
in apoptosis and negative feedback cascades in the disc.18 Additionally, as this nutrient
highway is blockaded an accumulation of lactic acid causes a drop in pH, which has been
reported to downregulate PG/GAGs and protein production.10
It is well known that the IVD changes with age. Overtime, the central NP becomes
more fibrous,18 losing its osmotic capacity and thus impairing the IVD retention of water.
Additionally, the cells themselves in the IVD are known to have limited capacity for matrix
repair or protective measures coupled with progressive loss of cell density has been linked
to IVDD.10,18,20 Lastly, the IVD becomes populated with inflammatory cytokines causing
degeneration which will be addressed in detail in a subsequent section. Together all these
factors mean that the cells present in the disc, begin to experience nutrient deficiency. The
ECM turnover rate becomes imbalanced and ECM synthesis decreases. The cells’ ability
to repair or synthesize more ECM is further limited, leading and vascularization, decreased
retention of water, and loss of IVD height.
II.2 Inflammation of the IVD
One aspect of IVDD that has been studied and continues to be a key scientific
question yet to be fully addressed is the influence of inflammation on the degenerative
cascade of the human IVD. It has been studied and stated numerous times that IVDs
removed from patients with sciatica or LBP had elevated levels of various inflammatory
cytokines such as interleukin (IL): IL-1𝛼, IL-1𝛽, IL-6, and tissue necrosis factors (TNF):
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TNF- 𝛼 among others.6,18,29,33 Of these cytokines, in IVDD the most prevalently studied
are IL-1𝛽 and TNF-𝛼.34 These proinflammatory cytokines trigger cascades that break
down ECM components and decrease cell ECM synthesis of the IVD through the activation
of catabolic enzymes such as matrix metalloproteinases (MMPs) and disintegrin and
metalloproteinase with thrombospondin motifs (ADAMTS).6,29,35 These MMPs and
ADAMTS are activated through NF-ketaN and p38/MAPK pathways.6
A short review of this cascade can be described with TNF-𝛼 which is most strongly
associated with IVDD in the NP specifically.6,32 TNF- 𝛼 has two distinct receptors named
TNFR1 and TNFR2 respectively. TNFR1 has two distinct signaling complexes: 1) the antiapoptotic complex I and 2) the death-inducing signaling complex. Once complex I becomes
activated there is a cascade causing NFKB/MAPK signaling cascades to begin mediating
ECM decomposition.6 Furthermore, TNF-𝛼 causes an increase in nitric oxide (NO) in the
IVD which consequently causes inflammation.29,32 Finally, TNF-𝛼 signals the nearby cells
to produce other proinflammatory cytokines inducing a vicious cascade linked to IVDD.
Although the understanding of metabolic pathways is better understood in IVDD
the role of each proinflammatory cytokines, or their regulators are still relatively unknown.
Furthermore, as IVDD understanding increases so do the potential influencers. For
example, Koerner and colleagues discovered in 2016 that substance P caused upregulation
and added to the inflammation in IVDs.35 Therefore, it is vital that as IVDD research
develops, these cytokines are included in the efforts and culture of not only IVD cells but
tissues as well to better resemble the pathogenesis of the disease.
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related activities.36 Beyond life-style or medical risk factors another key player in IVDH is
thought to be associated with the loss of boundary between the AF and NP which occurs
in humans as early as the second decade of life.5,18 The loss of the clear boundary is likely
due to the fragmentation and leaching of PGs/GAGs out of the NP into the surrounding
IAF. It is also important to note that it is not known whether inflammation is the cause of
a herniation or a consequence of it, but inflammatory cytokines and macrophages have both
been identified in human IVDH discs.37 Furthermore, one prevalent theory of IVDH onset
is that the IVD needs to be flexed or overloaded in multiple modes simultaneously and is
more likely to occur under higher loads.17
The consequences of IVDH can vary drastically. The protrusion or extrusion of NP
material can compress, irritate, or chemically agitate the nerve root especially if occurring
posterolateral IVDH in the lumbar discs.5 This irritation of the surrounding nerves can
cause debilitating pain. Furthermore, the displacement of the NP modifies the mechanical
integrity of the IVD which can alter the mechanical stability of the spine. With IVDH being
the most predominant form of IVDD, there is a vital gap of knowledge that needs to be
explored in the causation of IVDH and subsequent consequences of the pathogenesis of the
disease. In the past, more light has been shed on IVDH, but there remains much more to
be discovered to adequately repair or reverse the consequences of IVDH.

III. Current Treatment and Repair Strategies for IVDD and IVDH
With the pathogenesis of IVD varying so drastically, medical experts have created
various methods of non-surgical and surgical intervention. For most patients, IVDD is
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unknown to them until debilitant pain occurs. Most physicians will ultimately rely on
magnetic resonance imaging (MRI) or magnetic resonance spectroscopy (MRS) following
X-ray diagnosis, but full diagnosis methodologies can vary. For example, a contrast
medium in conjunction with MRI can be used to stain the CEP for radiating tears which
would suggest vascular ingrowth representative of IVDD.26 Alternatively, MRI T2 and T1𝜌
mapping utilizes the water content of the IVD and can be used in conjunction with a
diagnosis scale such as the Pfirrmann scale.26,38–40 Other grading scales have also been used
to assess and quantify the degree of IVDD or associated LBP such as the lumbar visual
analog scale (lumbar VAS) and Japanese Orthopaedic Association back pain evaluation
questionnaire (JOABPEQ) among others.26
Once physicians diagnose the IVDD, they can use varying routes of treatment,
namely conservative treatment, surgical, or intradiscal injections. Conservative treatment
options can range from exercise, bed rest, physical therapy, or oral medication.32,41 Prior to
surgical intervention, a physician might try drug therapy which can either be steroidal or
glucocorticoids via intradiscal injection.41 However, recently these injections have been
disputed, as a needle must puncture the AF potentially, causing a path for subsequent
degeneration.30 Although injection has been linked to potential downstream consequences,
intradiscal injections, when applied appropriately and early enough, are known to help
alleviate inflammation associated with IVDD.29 Regardless, all of these methods treat the
symptoms of the IVDD state, rather than reverse its pathogenesis.19,38
For some patients, surgical intervention may be required. Currently, there are three
major surgical procedures used: 1) total IVD replacement (TDR) using an artificial
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mechanical disc, 2) spinal fusion, and 3) discectomy for IVDH.41 In recent decades, spinal
fusion has become known as the gold standard for treating IVDD, especially as a late stage
intervention.19 Between 2012 and 2017, over 600,000 lumbar fusions occurred in medicare
patients alone.42 In contrast to fusion, TDR allows for an artificial mechanical support of
the spine while allowing some flexibility, which is thought to be an improved outcome.19
It has been found that both TDR and fusion boast great and similar short term results,
especially regarding pain, but might impair or cause subsequent degeneration in adjacent
IVDs.19 Discectomies will be addressed in depth in the following section. In short, all
current treatments lack full reversal of IVDD/IVDH, so a large gap exists to find the next
generation of treatments.

III.1 Discectomy
For patients who experience an IVDH, about 10% still experience pain following
conservative treatment such that surgical intervention must be considered.36 Discectomies
are a very effective treatment for IVDs in the lumbar spine allowing for the decompression
of nerves.2 Discectomies work by removing the protruded/extruded NP to try and restore
native IVD function. There are two general routes a surgeon might take, conservative or
aggressive discectomy as depicted in FIGURE 1.3. There were 287,122 surgical
discectomies procedures in 2002 resulting in over 350,000 lumbar spine levels operated on
in that year.43 These numbers are only expected to increase with mean population age and
average patient weight increasing.
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Figure 1.3. From left to right: depiction of a herniated disc, extruded NP removal, conservative
discectomy, and aggressive discectomy.

Although, discectomies yield great results from many patients they have their
consequences as well. For example, the re-operation rate for discectomies ranges have been
reported from 11% up to 15%,2,43 furthermore, 28% of patients who underwent discectomy
reported unfavorable outcomes.43 With each re-operation procedure there is a direct burden
of cost, with each repeat discectomy adding $6,900 procedural costs43 with overall
additional cost reaching up to $39,836 to $49,431.44 Sometimes, discectomy failure even
results in subsequent spinal fusion which can add a 350% increase in cost.43 The high
revision and failure rate associated with discectomies may be linked to the current
procedure methodology which could weaken the AF, exacerbating future degeneration in
the form of re-herniation or subsequent total IVD degeneration.2,9

III.2 IVDH Approved Devices and Technologies for IVDH
With discectomies becoming so prevalent and their inherent weaknesses, there has
been a large effort to create medical devices that can be used in conjunction with the
discectomy procedure to replace the damaged or lost NP and AF tissue. For example,
Tisseel©, a hydrogel that is commercially available, has been used for herniation repair.22
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It is important to note that this fibrin-based hydrogel is FDA not approved for neurologic
surgical usage. However, this fibrin-based product among others has been evaluated in
literature or served as the premise for some potential future therapeutics and therefore was
found significant to mention.
Another style of mechanical device sought to improve the outcome following
discectomy are the BarricaidTM and Anulex-XcloseTM systems.19,44,45 One study suggested
that these devices were able to reduce re-herniation rates without increased risk of
durotomy, wound complications, or epidural hematoma.44 One study even found that the
Anulex-XcloseTM boasted only a 9.8% re-herniation rate at 2 years post-implantation.45
Both of these devices sought to help in annular closure in discectomies. It is important to
note that only the BarricaidTM device has FDA approval, and the Anulex-XcloseTM is no
longer on the market. Therefore, the annular closure market is very young and vitally needs
more solutions that are safe and effective. If AF closure could be improved there would be
a direct positive impact on human life and discectomy outcomes.

III.3 Tissue Engineering and Future Technologies for IVDH
With so few technologies and no ideal solution on the market for IVDH repair or
IVDD repair, there remains a huge gap in the biomedical field. Many bioengineers have
sought to create and apply tissue engineering constructs to fill this void with varying levels
of success. In short, tissue engineering takes scaffolds of natural or synthetic variety to
interact with cells creating a viable ‘product’ that ideally mimics the native tissue,
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decreases recovery time, integrates with surrounding tissue, and maintains proper cell
signaling, ECM production, and morphology.46
Two tissue engineered scaffolds of significant importance to the work herein are
the acellular bovine nucleus pulposus (ABNP) and annulus fibrosus repair patch (AFRP),
which have previously been created by the Ortho-X Laboratory. The ABNP uses a novel
decellularization method to remove cell and genetic residuals from bovine NP tissue to
create a biomimetic scaffold that once crosslinked mimics the ECM, structure, and strength
of the native NP.47,48 The AFRP is a series of stacked and sewn decellularized pericardium
layers that mimics the native OAF which supports cell viability, cell differentiation, and
puncture resistance which could be implemented on the OAF following a discectomy to
potentially reduce re-herniation.49–51

IV. Current Methods for Evaluating the Efficacy of IVDH Treatment Strategies
With so many factors playing a significant role in IVDD, researchers have
developed many strategies to study the pathology, progression, and potential therapeutics.
Most cell and tissue engineering scaffolds are evaluated first in vitro and eventually in vivo
animal studies or human clinical trials.

IV.1 In Vitro IVDD and IVDH Research Efforts
In vitro studies use controlled environment experiments to assess cells and initial
cytotoxicity studies; however, for IVD research this realm has evolved many unique
aspects. For example, since IVDD is characterized by unique environmental conditions
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beyond that of normal culture some researchers have tried to implement these. Although
many aspects of IVDD might be believed to be understood, such as the role of TNF-𝛼, IVD
pathology still needs to be studied and explored further. Recently, it was determined that
both human or bovine TNF-𝛼 could induce the same inflammatory response in bovine NP
cells,29 which allows for the more ethical discovery of TNF-𝛼’s unique role in IVDD cell
apoptosis or degeneration. In vitro studies like this one allow for the isolation study of
specific variables of IVDD. With a better understanding of the individual roles and factors,
the complex pathogenesis might be better understood.
Although there are benefits to the manipulation of single variables of IVDD, there
are many limitations of 2D cell culture in vitro. Many studies have discovered that the
phenotype of cells might change while in 2D culture. This is especially true for culturing
of NP cells which have been shown to rapidly de-differentiate even within the first passage
of 2D culture. These cells were shown to have decreased matrix synthesis of type II
collagen and aggrecan while an increased production of type I collagen.15 This dedifferentiation has even been suggested to occur in AF cells as well. Therefore, various
groups have developed alginate bead encapsulation methods to study IVD cells.20,52,53. It
is essential for cells used in IVDD research to not de-differentiate, not only for purpose of
the cell’s phenotype but also ethically as there is only a limited amount of tissue available
from which the cells can be acquired from.52
Naqvi and colleagues took alginate IVD cell culture one step further by developing
a unique co-culture model. These researchers used an alginate mold with a central ring of
NP cells in alginate surrounded a central core of either bone marrow derived mesenchymal
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stem cells (BMSCs) or NP cells and BMSCs. Prior to co-culture BMSCs were
differentiated toward a discogenic phenotype and were preserved using a microcapsule
technique. Ultimately, using this model researchers were able to determine specific
changes of each cell type or co-culture in physiologic and pathological pHs of 7.4 and 6.8,
respectively. The study found that the increased acidity associated with IVDD was found
to reduce cell proliferation and decreased GAG content.53 Multifactorial co-cultures like
this study allow for better extrapolation of potential future therapeutics such as BMSCs
while also better modeling the IVDD environment; however, their complexity makes them
difficult to replicate.
It is for this complex reason that some lesser-known influencers on IVDD are still
explored individually like osmotic pressure. Researchers have changed the osmotic
pressure in standard cell culture medium (CCM) to hypo-osmotic (255 mOsm), hyperosmotic (450 mOsm), and iso-osmotic (293 mOsm) to study these changes on IVD cells.9,10
In degenerative IVDs the osmolarity decreases trending towards hypo-osmotic
conditions.54 In a simplified co-culture model of cells from the NP and transition region of
porcine IVDs it was found that hypo-osmotic pressure caused upregulation of aggrecan
and type II collagen in transition cells but not NP cells.9 It was hypothesized and suggested
that this difference in response to osmolarity might be due to the NP’s more developed
actin cytoskeleton.9
Although some researchers can use in vitro studies to find the roles of known
influencers of IVDD others are able to use its unique controlled environment to find
potentially new influencers. For example, melatonin was recently discovered to decrease
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catabolic MMP-3 and increase aggrecan and type II collagen production in NP cells even
in the presence of IL-1𝛽. Ultimately, in vitro studies are vital to study fundamental
influencers of IVDD while also discovering new avenues to counteract degeneration. It has
even been suggested that culturing of AF and NP cells prior to experimentation should be
standardized to mitigate the influence of potential de-differentiation or cell lineage.15
Although there are many benefits to in vitro studies extrapolation and translation to in vivo
remains difficult.2,15

IV.2 In vivo IVDD and IVDH Animal Studies
Since the complex multi-factorial environment of the IVD is hard to replicate, many
researchers have sought to use in vivo animal models to study the IVDD and IVDH as well
as potential therapeutics. Commonly used experimental animal models range from mice,
rats, rabbits, dogs, sheep, and pigs to alpacas or kangaroos.15,55 Although so many varying
animals selected might seem unreasonable many have unique characteristics for complex
studies. It is important to note that most animal models are quadruped-based and are
suggested to have distinct biomechanical properties varying from the human spine.22 Some
of the benefits to some common models will be addressed below.
Since quadrupeds have obvious mechanical loading differences compared to the
human condition some researchers have sought to use biped non-human primates such as
the baboon, rhesus monkey, or even kangaroos.55 It was found that the kangaroo lumbar
vertebra, while biped in nature, had a smaller vertebral body and increased vertebral body
height. In fact, in a review of other animals, it was found that there was no perfect match
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induce injury and subsequent IVDD.34,56 Not only are these animals great for studying the
influence of inflammation on IVDD, but also other disease states such as diabetes. For
example, diabetic RAGE-KO mice models have been used in conjunction with known
IVDD mice models to determine the compounding disease states.21 Although these small
animal models are great for studies mentioned previously, they still lack key physiological
correlations to humans. Particularly, the scaling of the small animals and syringe-based
initiation of IVDD has difficultly in scaling to larger animal models or extrapolation to
humans.30 Furthermore, the fundamental cell biology of many smaller animals is different
from the human condition many do not lose their notochordal cells like humans even at
maturity.22
Due to the similarity in size, many researchers have moved to larger animal models
of in vivo studies. With animals such as dogs,19 sheep, and pig models there have been
IVDD models using an annular lesion technique.30 However, these models come at a large
ethical and cost burden.15 Furthermore, some research suggests contradicting results in
animals relative to in vivo studies in humans suggesting that in vivo animal studies should
not be the sole indication for potential therapeutic success.15 Although in vivo studies have
their limitations they are essential to the research and improvement of future IVDH
treatments; yet, there is a huge need for a better, cost-effective means of going from in vitro
to in vivo studies.

V. Organ Cultures
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V.1 Murine IVD Organ Culture
Murine (mouse) IVDs (mIVDs) are commonplace for use in IVD organ culture.
Murine IVDs benefit from the low cost and scalability that small animals can have.
Furthermore, mice benefit from genetic modification and selective breeding allowing for
potential knock-down or up-regulated genes.21,24 Also the small size of the IVDs allows for
many to be cultured in smaller confined areas. One study that took advantage of these
benefits used WT and RAGE-KO induced diabetic mice and cultured the mIVDs for 10
days in the presence of AGE-BSA. The RAGE-KO mice were found to show no subsequent
degeneration due to the AGE-BSA suggesting that it was a RAGE-dependent pathway of
IVDD.21 Studies like this one allow for the discovery of unique new pathophysiology of
IVDD and therefore are vital to the study of the disease state.
Other murine models focus on the induction of IVDH-like degeneration. Many will
allow for initial free swelling of the mIVDs for up to 24 hours followed by a subsequent
puncture with a 27-gauge needle.24,58 Abraham and colleagues were able to induce IVDH
like degeneration by puncturing the mIVDs 0.5mm deep causing an upregulation and
presence of IL-6 and a decreased IVD stiffness and loss modulus at both 1 and 5% strain
following 21 days in free swelling culture. A similar model found that a 27-gauge needle
puncture not only caused decreased stiffness and loss modulus but also decreased collagen
content, GAGs content, IVD height, and weight ratio.24
While some mIVDs organ cultures use a needle to cause degeneration, another
effective means found has been to use a mechanic load. Xing and colleagues are just one
of many groups which were able to induce injury using a dynamic mechanical compression
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doe 1.5 hours for 7 days at -0.5 MPa at a loading rate of 1 hz relative to static culture.7
Others have taken a simpler path to degeneration through various static loads.59 From these
models there have even been assessments of the role of key players of IVDD such as
MAPK inhibitors. Under static load in the presence of MAPK signal pathways blockers,
there was increased cell apoptosis even after 24 hours suggesting although MAPK might
play a role in degeneration it also plays a role in IVD resistance to mechanical loading.59
Organ culture has even evolved a subcategory within mIVDs known as a “disc-ona-chip” model. Researchers use computerized fluidics systems with these small IVDs to
create easy-to-implement capabilities and recreate interweaving/confounding variables
with direct extrapolation of results or data sets from the computer monitoring. IVDs in
“disc-on-a-chip” systems have maintain higher viability than static cultures.60
Although murine models are prevalent in literature they still suffer from some key
limitations. First and foremost, their size is significantly different from the human lumbar
IVDs where IVDD/IVDH is most prevalent which results in altered nutrient gradients
inside the IVD. Therefore, capturing and replicating in vivo human loading and translating
to the mIVDs is particularly difficult.24 Also many times in my literature findings these
discs were acquired from recently deceased mice from various available sources, such as
alternative projects, and then subsequently sourced for mIVD culture. Although this
drastically helps elevate ethical concerns directly following the 3Rs of animal research,
scientists must carefully ensure proper screening not to induce potential confounding
variability.
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V.2 Rat IVD Organ Culture
Much like mice, rats have become a popular small animal model for organ culture.
These discs have largely been used to test axial and hydrostatic compression’s influence
on cell viability and overall IVD structure; however, the experiments were not able to
reproduce the shear loads experienced by human IVDs.11
Some researchers have shown that with vertebral bodies attached, rat IVDs lost
significant mechanical integrity following even only 6 days in free swelling culture.61
However, it is important to note that there was no influence following only one day in free
swelling culture.61 Other researchers have used rat IVDs to study cyclic compression
ranging from 0.25-0.5 and 0.25-1.0 MPa for 3 hours on 1 hour off for 4 cycles followed by
8 hours in free swelling. They found that that there was a magnitude-dependent response
to inflammatory cytokines such as IL-1𝛽, IL-6, and IFN-𝛾.4 Therefore, suggesting that in
small IVD such as rat IVDs cyclic fatigue loading could be a potential model for induction
of IVDD.
While many scientists focus on the role of loading on rat IVDs, others use them to
discover potential new factors that might influence IVDD. For example, substance P (SP),
a neurologic pain stimulant found in the body, was linked to IVDD. It was found that in a
free swelling culture rat IVDs treated with SP showed an increase in inflammation,
therefore, linking SP as a potential player in the degenerative inflammatory cascade of the
IVD.35 Others study lifestyle choices such as caffeine. In an IVDD induced rat model
following an IVD puncture/aspiration method, IVDs were cultured in varying levels of
caffeine. In the organ culture, it was determined that caffeine exposure caused decreased
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cell viability and altered ECM composition. Therefore, caffeine might intensify the
negative impacts of IVDD or even accelerate the progression of the disease pathology.31
Lifestyle choice studies such as this one are essential to determine what a patient with
IVDD might be able to change without medication to improve potential outcomes
associated with IVDD.
Just as mIVD organ cultures rat organ cultures have their challenges. Some
researchers found that there was substantially decreased viability following culturing 14
days and longer.13 It is therefore important in any organ culture to continuously monitor
cell viability and not to proceed beyond timepoints that might negatively impact results. It
is important to note however that some researchers have shown that IVDD can be induced
within 14 days with hallmarks of loss of notochordal cells and up-regulation of MMP-3
and MMP-13 gene markers.11 Therefore, if viability is maintained these discs have an
important role in potential IVDD/IVDH breakthroughs.

V.3 Rabbit Organ Culture
The last significant small animal organ culture model uses rabbit IVDs (rIVDs).
With rIVDs IVDD can be inducted using needle puncture methods like rat IVDs.19,30,39
Some groups have used these models to assess the potential consequences of intradiscal
injections such as lidocaine or bupivaccine. With previously induced IVDD using a needle
puncture technique, rIVDs that received both lidocaine and bupivaccine saw decreased NP
cell viability.39 While IVDD can be induced in rIVDs some have suggested that these
degenerative characteristics are not as drastic as it is in similar rat IVD models.11 Therefore,
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just as with any organ culture model it is essential that scientists publish experimental
procedures precisely so that consistent and replicable IVDD onset can be induced
regardless of the animal species.

V.4 Caprine Organ Culture
Less common but significant are caprine (goat) IVD (cIVDs) organ culture models.
These models allow for a bridge from a small animal such as murine, rat, or rabbit to a
moderate-sized IVD. Within these models the effectiveness of collagenase and cABC
injections to cIVDs has been assessed in organ culture. Following culture, both cABC and
collagenase caused substantial NP destruction indicative of severe IVDD.28 These models
might be beneficial for laboratories in regions of the world where other larger animal
models might not be accessible due to the availability of religious factors. Furthermore,
they could potentially serve as a smooth transition to “large” animal in vivo studies as
animals larger than a goat become challenging to find across the world.

V.5 Porcine Organ Culture
Porcine (pig) IVDs (pIVDs) are one large animal organ culture used to study IVDD.
One notable study in this realm looked at how static and dynamic loading influenced NP
cell degeneration. Uniquely, this study had three groups, namely an unloaded control, a 0.4
MPa for 4 hours static culture, and a 0.4 MPa at 1 Hz for 4 hours dynamic culture. It was
found that dynamic culture maintains NP cell’s native structure and function most
effectively, with negative impacts from the static culture.38
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V.6 Bovine Organ Culture
The most prevalent organ culture selection is bovine (cow) IVDs (bIVDs). These
IVDs are great candidates as they have been shown to be similar in composition to human
lumbar IVDs boasting similar hydration, collagen, and PG content and synthesis.12,22,62
Furthermore, bIVDs have similar responses to flexion and extension as well as bending
and torsion relative to the human lumbar disc.10,12 The best area to isolate bIVDs is from
the coccygeal/caudal region which is the upper portion of the tail. Furthermore, these
bIVDs are highly available in many cultures from local abattoirs or meat markets allowing
for significant and cheap accessibility.
With the prevalence of bIVDs in IVDD organ culture many techniques have been
used to induce injury ranging from needle punctures to biopsies. For example, one group
used a 21gauge needle in conjunction with 100ng/mL of IL-1𝛽 supplementation to induce
degeneration in a static .46 MPa loading model. Using this model subsequent testing of
intradiscal injection of nonsteroidal anti-inflammatory drugs or MSCs were evaluated.41
Other models have used a biopsy punch to mimic a nucleotomy to assess hMSCs27,53,63 or
using custom AF injury punches.27 One group has even taken this idea of a nucleotomy
and applied it through the CEP to mimic a Schmorl’s node.64 Lastly, other models are able
to induce degeneration using a mechanical loading regime such as torsion65 or a single
high-impact loading event.12
With so many methods of introduction of IVDD, it is not surprising that bIVDs
have become so common. While degeneration models are well established in bIVDs, many

26

studies are still plagued by the gradual decrease in cell viability while in culture especially
with such a large tissue source as the bIVD. One researcher, therefore made a proprietary
CCM named PrimeGrowthTM which allowed for high cell viability out to 5 months in
culture.23 While others have shown that the removal of the vertebral bodies could increase
cell viability in static culture8 or by subsequent removal of blood clots out of the CEP using
a sterile saline lavage system.10,66 Lastly, others have combated the decreased viability in
bIVD culture using dynamic compression.62
Some notable breakthroughs that have been discovered or studied in bIVDs are the
influence that intradiscal injection needle size might have on subsequent degeneration.
When comparing a 25 gauge needle to a 14 gauge needle it was discovered that in bIVDs
there was a significant change in mechanical creep as well as localized cell death along the
injury path.30 Therefore, it might be implied that needle size might actually cause injury to
human lumbar IVDs as well and should be considered with intradiscal injection. While
other bIVDs organ cultures have assessed the interaction macrophages might play if
interacted with the IVD, resulting in down-regulated degenerative IVD gene markers.
Using a co-culture bIVD and human macrophage model, it was determined that when in
the presence of IL-1𝛽, both IVD and macrophages increased inflammatory response by
upregulation of IL-6. However, once co-cultured in the same inflammatory environment
there was a decrease in IL-6 production in the IVD cells relative to when they did not have
macrophages added in the system37 Although many potential therapeutics have been
evaluated in bIVDs as well as many pathological breakthroughs discovered there is still
much more room for improvement.
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VI. The Requirements and Considerations for Successful IVD Organ Culture
With so many variations and models for IVDD organ culture, there are numerous
considerations that must be explored prior to starting experimentation.

VI.1 Organ Culture Selection and Preparation
The first consideration for IVDD organ culture is animal selection. A scientist must
determine what availability of fresh tissue there is around them and what kind of study they
would like to complete. Ideally, human tissue with a known degree of degeneration should
be acquired, but due to ethical concerns and availability, this is not possible.37 If they want
to study the influence of a particular gene then mice, rodents, or rabbits might be an ideal
candidate as these animals have controlled and established breeding of genetic variations.
These animals are particularly viable if a nearby institution has animal study laboratories
on-site or nearby as the animals could potentially be euthanized from an alternative study
if there is no degeneration to the IVDs prior. However, these small animal IVDs will suffer
from having notochordal cells,22 hard to implant tissue constructs, and significantly
different in size relative to the human lumbar IVD. If these challenges might directly impair
the research required a larger animal such as a porcine or bovine model might be a better
choice. These larger discs come with their challenges as well. First, ethical and regional
religious considerations should be kept in mind prior to sourcing tissue. Secondly, there
must be a local vendor, such as a slaughterhouse or butcher that can deliver or allow for
tissue acquisition within 24 hours postmortem ideally 4 hours.66
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Once tissue choice has been determined, proper techniques for isolation and culture
must be considered. Once the skin has been removed it is best practice to allow the tissue
to rest in betadine especially if acquired from a non-aseptic environment.66 Furthermore,
many cultures will then allow for subsequent rinses in a 70% ethanol solution.8,22,27,63,65,66
Once the tissue has been rinsed and initial steps to mitigate contamination have been
implemented the IVDs may be isolated. It is important to note that additional rinses or
washes in solutions to reduce contamination should be implemented once the IVD is
isolated. Once the IVD is isolated from the surrounding tissue there are many
considerations. First and foremost, due to the osmotic swelling of the IVD and removal of
surrounding tissue, a major concern is IVD swelling.10,22 Therefore, it might be integral to
maintain the CEP to reduce the consequences of the swelling as well as allow for more
natural nutrient exchange.10,22,23 With the BEP or CEP attached it has been shown that
removal of blood clots using a lavage water pik, which allows for increase diffusion and
nutrient transport.66 Once all of these considerations have been implemented an IVD may
be considered ready for subsequent culture with caution.
The next consideration is the mode of culture that is required for the discs: free
swelling, static culture, or dynamic culture. If free swelling is considered it is best practice
to remove the BEP and only maintain the CEP allowing for easier nutrient exchange.23
However, many times these free swelling discs serve as controls and therefore BEP might
need to be maintained.27,38,63 It is important to note that the BEP in free swelling has been
shown to negatively impact cell viability and therefore careful consideration of time points
and cell viability must be considered if the BEP is not removed for free swelling culture.8

29

M)!7@0!.7@01!@+)9E!"6!57+7":!.1!9-)+3":!,.+9")L!:*,7*105!+10!905"109E!$]O!1070)7".)!+,,.N5!
6.1!+!*)"6.13E!6,+7!5*16+:0!")!.1901!7.!"34,030)7!7@0!,.+9")L!10L"30)5G!,(""("#!<)!.1901!7.!
+:@"0/0! :.)5"570)7E! 906")09! ,.+9")L! 10L"305! ")! 57+7":! .1! 9-)+3":! :*,7*10! 8".10+:7.15! +10!
*7","m09G!&@0!:*110)7!57+70!.6!8".10+:7.15!+)9!0/.,*7".)!.6!8".10+:7.15!")!<=>!.1L+)!:*,7*105!
@+5!10:0)7,-!800)!10/"0N09!")!9047@!0,50N@010!+)9!"5!5*33+1"m09!")!;/2<=9%('NG!,(""!

!"#$%&'()1!"H0$"$E)C>(&)*")+"G&)<$,'(&)*9"&*"-.#")<=,*"'>C(><$!!&#

2D

&@0!,+57!:.)5"901+7".)!6.1!5*::0556*,!<=>!.1L+)!:*,7*10!"5!7@0!"34,030)7+7".)!.6!+!
90L0)01+7"/0!4+7@.,.L-G!&@010!+10!C!3+V.1!4+7@N+-5!7.!90L0)01+7".)!:*110)7,-!057+8,"5@09!
+5!904":709!")!;/2<=9%('OG!,!<7!"5!"34.17+)7!7.!).70!7@+7!5:+,")L!)0095!7.!80!:.)5"90109!N@0)!
")9*:")L!90L0)01+7".)!0540:"+,,-!")!9060:7!3.90,5G!Q.1!0B+34,0E!"6!+!1<=>!"5!*509!"7!N.*,9!
80@../0!7@0!*501!7.!*50!+!)009,0I8+509!9"5:0:7.3-!")V*1-!1+7@01!7@+)!+!,+1L0!8".45-!4*):@G!
Q*17@013.10E! ,.+9")LI")9*:09! 90L0)01+7".)! 5@.*,9! +,5.! 80! 5:+,09! *5")L! <=>! 5"m0! +)9!
:1.55I50:7".)+,!+10+!7.!+:@"0/0!4@-5".,.L":+,!.1!4+7@.,.L":+,!41055*105!N@":@!3"L@7!10T*"10!
/+1-")L!6.1:05!6.1!0+:@!9"5:G!M):0!+,,!:.)5"901+7".)5!@+/0!800)!907013")09!7@0)!7@0!9"5:5!
3+-!80!:*,7*109!+)9!+)+,-m09!+7!7@0!410907013")09!7"30!")701/+,5G!

!"#$%&'()2!".,<&)>9"-.##";)6$C9"'><<$*(CF">9$6"&*")<=,*"'>C(><$!!&"

2J

VI.2 Potential Organ Culture Outcomes and Results
Although IVD organ culture benefits from the capacity to regulate and control the
mechanical and chemical environment surrounding the organ,62 extrapolation of results and
methodology of samples allocation must be considered. The most important test that must
be conducted is cellular viability. It should not be assumed that just because viability is
high at a terminal time point that cell viability did not change throughout the study’s
timeline. In addition to viability, some researchers have used the CCM surrounding the
IVD to run cytokine arrays for inflammation or other markers. Another common method
of measuring inflammation might be to run a series of gene expression experiments for
cytokines and MMPs.11,12 Lastly, tissue samples can be aliquoted at terminal timepoint to
measure ECM composition or degradation relative to a fresh control.
Another common outcome of IVD organ culture is histological evaluation of the
IVD types. There have been many IVD specific stains created over the years such as alcian
blue picrosirius red (ABPR), extended FAST stain, and others.67 Furthermore, using these
unique stains there are even histological grading scales to quantify IVDD.68 Beyond the
specifically designed IVD stains, standard stains such as hematoxylin and eosin (H&E) and
immunohistochemistry (IHC) are also beneficial for IVD organ culture.67,68
Lastly, IVDs can be evaluated mechanically. It is important to note that these tests
require intact BEP, for a flat platen to be secured properly prior to load application. Some
common testing parameters are acquired through dynamic creep and stress/relaxation
testing. Ultimately, there are nearly endless testing mechanisms that can be run against an
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organ culture however, predetermination and sample allocation is key as many avenues
require destruction or alteration to the IVD prior to testing.
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CHAPTER TWO
Gaps and Future Directions of IVD Organ Culture

I. Next Generation IVD Organ Cultures
Although IVD organ cultures are not new and have existed for a few decades, in
the future they must further evolve. In the past organ cultures were free swelling but there
has been a shift to static and dynamic culture.10 The future of IVD organ culture is much
more than the application of a loading regimen.
As IVD models have evolved over the years, they have served to bridge the gap
between in vitro and in vivo studies.29 Scientists have done so by manipulating and
regulating the biochemical environment such as through incorporation of inflammatory
cytokines.29,35,37,41 Others have relied on mechanical induced degeneration through
nucleotomy injury models.10 Some have even combined these two, for example, Teixeria
and his colleagues used a needle puncture in conjunction with IL-1𝛽.41 Dual-focused
models such as the previously mentioned, are the future of organ culture as they will allow
for faster degeneration and more realistic comparison to in vivo. Once scientists can start
to incorporate multifactorial IVDD models into one a standardized and expedited holistic
model will become more realistic.
As a more multifactorial injury model with inflammatory cytokines and other
compounding factors is utilized, then the next generation of tissue engineered scaffolds
could be implemented. Some researchers have started to use IVDD organ culture models
to test therapeutic strategies already.10,22,53,63 Others have started to test the efficacy of
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human MSCs (hMSCs) in organ culture models to assess their capability to differentiate or
help in the reversal of degeneration.10,22,64,69 The utilization of IVDD models for assessing
these vital steps in future tissue engineered IVD constructs will be essential for safety and
efficacy testing. As more models are validated there will be more strides towards
combining tissue engineering scaffolds, hMSCs, and pre-differentiated cell lines into
reality.
With the next generation of tissue engineering scaffolds being implemented into
IVD organ cultures one vital effort that must be explored is the execution of surgical
implantation procedures. Even if a perfect technology would be implemented it would need
to be viable within standard surgical techniques and these parameters could be explored in
an organ culture prior to testing in an animal where the procedure would become more
challenging and hold a high ethical burden. Some new surgical techniques that have yet to
be implemented in an organ culture model, to the best of the author’s present knowledge,
such as a new novel jetting suture recently published which boasts of significantly reduced
re-herniation rates following discectomy.45
Lastly, the duration of organ cultures likely will need to increase with many studies
on exploring out to the 14 or 21 day time point.10,22 If more cultures are able to achieve a
multi-month time point such as those conducted with PrimeGrowthTM then more complex
mechanisms or reversals of IVDD might be explored.23 Although organ cultures likely
never will eliminate the need for in vivo studies they can directly decrease the number
required, particularly for preliminary feasibility and testing of tissue engineered constructs.
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II. Next Generation Testing Strategies
As organ cultures become more evolved so must their testing strategies. For
example, as inflammatory cytokines are supplemented to CCM this will directly impact the
cytokine testing arrays that should be used to determine the intensity or presence of
inflammation. Specifically, if one added IL-1𝛽 to CCM then one should use other
cytokines to check for the presence of inflammation such as IL-6 or TNF-𝛼.4,58 Other
potential avenues to measure the inflammatory response of an IVDD organ culture model
is to continue monitoring MMP3 and other genes associated with inflammation as
previously studied.11,12
Another testing strategy that will be required for future IVD organ culture is new
histological grading scales. Many grading scales are use the symmetry of the IVD
alongside hallmarks however, many IVDD organ cultures must induce an injury to one
side of the IVD which directly biases these grading scales. Therefore, as the injury inducing
models develop into their final respective states a series of new grading scales will need to
be developed analyzing not just the whole IVD but each distinct side of the disc.
Next, with the implementation of more hMSCs into the organ cultures for their
efficacy testing one approach which might be beneficial is using specialized cell tagging
to keep track of the hMSCs migration. One potential avenue would be to use transfection
of the hMSCs with a green fluorescent protein (GFP) prior to implementation in the organ
culture as has been proven viable in vitro.70 The one caution that would need to be
considered is that GFP may interfere with cell viability arrays and therefore caution would
need to be used when determining which array should be used. The tagging of hMSCs
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might be particularly important in injection-based therapies where cells might not be
attached or pre-adhered to a scaffold.
With the implementation of hMSCs comes another key challenge, tracking their
differentiation. In vitro studies have shown that there are numerous key NP cell phenotype
markers such as CA12, HIF-1a, FOX1, PAX1, GLUT-1, Brachyury, CA24, LAM-511, and
LAM-332.15,71,72 While these markers have been used to differentiate NP cells from
chondrocytes or to determine the effectiveness of differentiation of hMSCs to precursor
NP cells these markers have yet to be studied in organ cultures. Therefore, potential dedifferentiation might be occurring, which could become a larger factor as culture time
points are extended.
The aim of this work was to address some of these current challenges for organ
culture. Although organ culture is significantly cheaper than in vivo animal studies there is
still a financial burden associated with IVD organ culture. To create a cost-friendly culture
model a specified free swelling model that could easily be replicated would be explored.
Based on previous literature, free swelling culture still has a significant role in the field as
it is often used as a control group for studies conducted with bioreactors4,27,38,63 or paired
with nucleotomy induced degeneration.35,53,58,61,64 However, to improve on previous
models, the combined successes of each should be implied. Therefore, not only would the
vertebral BEP be removed exposing the CEP, but a jet lavage rinse to remove blood clots
which has been shown to improve viability66 and the implementation of PrimeGrowthTM
mediums should be implemented.23 With these improved isolation procedures, a defined
aggressive discectomy can be created which would be replicable between our lab and
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others alike. Beyond the improvements of the free swelling conditions an in-depth
histological analysis of cultured bIVDs should be defined and standardized. Therefore,
using previous histological stains found in literature for IVDs a grading scaling that would
define microarchitecture changes such as AF lamellae distortion should be created that will
look at each side of the IVD independently. Once having created and applied all of these
elements, the culture could then serve to test the therapeutic effects of two novel scaffolds:
the AFRP and ABNP, to help augment the aggressive discectomy procedure.
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CHAPTER 3
Aim 1: Influence of Aggressive Discectomy in bIVD Organ Culture Cell Viability

I. Statement of Purpose
A low-cost aggressive discectomy model was sought to be created. If the model
could be successfully created it could be used to study the efficacy of new surgical
techniques, tissue engineered constructs, or add to the general understanding of IVDD
pathology. To create the model, it was determined that not only should an annular puncture
be used as in the previous model, but subsequent NP material should be removed as well.
Furthermore, although previous discectomy models have shown to induce an inflammatory
response,58 additional supplementations of both IL-1𝛽 and TNF-𝛼 in CCM was warranted.
While many organ culture models have shifted from free swelling, there is a direct cost
saving without the application of load or complex bioreactor setup. Additionally, to allow
for long-term culture aspects previously shown to help aid free swelling culture should be
applied such as the use of PrimeGrowthTM which has shown to drastically increase longterm viability,23 and removal of the bony endplate to help with nutrient and waste
transport.10,22,66 The model ultimately sought to combine factors from various previous
studies into one defined free swelling culture that would maintain high viability.
It was hypothesized that bIVDs can be injured using surgical tools to create an
aggressive discectomy while maintaining viability in culture.

II. Methods and Materials
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Following isolation, discs were prepared for aseptic conditions. Discs were
transferred to fresh cups with 2% AB/AM solution and agitated for 5 minutes at 150 rpm
on an orbital shaker. Discs were then rinsed in a 0.1% peracetic acid solution for 2 minutes,
followed by 5 minutes in 70% EtOH. Discs were then once again placed into a 2% AB/AM
solution that was pre-marked on the outside of the specimen cup with the solution level.
Once the IVD was fully submerged the new solution level was measured. Discs were then
transferred to new cups containing 50 mL of PrimeGrowthTM Isolation Medium (Wisent
Bioproducts; Quebec, Canada) per manufacturer instructions, and bIVDs were incubated
at 37oC for 2 hours at 150 rpm. While incubating, the bIVDs volume was determined using
the marked AB/AM containers, and discs were randomly assigned to one of three groups:
Control, Injury, and Repair. Once discs were incubated, they were neutralized with
PrimeGrowthTM Neutralization Medium (Wisent Bioproducts; Quebec, Canada) three
times in 50 mL for 5 minutes. Discs were then separated into their respective groups for
culture.
Control group samples were placed in new specimen cups with a standardized
medium quantity based on their volume. These samples were cultured in high glucose
DMEM culture medium with sodium pyruvate and L-glutamine with 10% fetal bovine
serum (FBS) and 2% AB/AM. The IVDs had their CCM refreshed every 3 days until their
final time points of 2, 14, and 30 days. The specimen cups were sealed using a BreatheEasy® sealing membrane (Diversified Biotech; Dedham, MA).
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CHAPTER 4
Aim 2: Histological Characterization of the Aggressive Discectomy in bIVDs

I. Statement of Purpose
Following the creation and validation of a viable aggressive discectomy model, as
described in the previous chapter, the next step was to characterize the degeneration using
histological assessment. Histology staining will help validate hallmarks of degeneration
such as decreased cellularity, decomposition or alteration of ECM, and changes in
microarchitectural structure such as changes in AF lamellae thickness or orientation. By
using specified stains each of these factors could be assessed. H&E can stain for basic ECM
composition while also staining for cellularity. ABPR can be used to stain for the ECM
composition of collagen to GAGs which is essential to maintain IVD structure, function,
and nutrient influx. Finally, holistic staining such as modified FAST stain will allow for
detailed microarchitectural analysis. Beyond measuring and assessing the bIVDs under
these stains a grading scale that would isolate each side of the IVD could potentially be
created which could serve as a future validation or hallmark assessment of IVDH.
It was hypothesized that bIVDs that underwent the aggressive discectomy would
show morphological hallmarks and microarchitectural changes following culture in a free
swelling environment.

II. Methods and Materials
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Following 30 days in free swelling culture bIVDs from the Control and Injury group
were fixated in 10% buffered formalin for 48 hours. Following fixation, the bIVDs were
decalcified using ImmuncalTM (StatLab Medical Products; Columbia, MD) which was
refreshed every 3-5 days until endpoint assay showed no signs of calcium present.
Following, decalcification lateral ends of the bIVD were removed so that only the medial
6mm of tissue was preserved (Injury group had the injury central in this cross-section). The
tissue was further fixated for 24 hours in 10% buffered formalin. Following final fixation,
bIVDs were processed prior to being paraffin-embedded.
For each sample, ten 7 𝜇m thick sections were collected (Injury was trimmed until
the discectomy was visible on sections and then ten sections were acquired) representing
at least 250 𝜇m cross-sectionally of the tissue. Two sections were subsequently used for
H&E staining, two for ABPR, and two more for modified FAST stain while the remaining
4 were stored or used for troubleshooting.
Slides stained for H&E were imaged in the AF, NP, and CEP. For AF and NP, three
representative images were imaged at 100x using an Axiovision Vert.A1 microscope
(Zeiss; Oberkochen, Germany) and cellularity was determined per field of view. The three
images were then averaged together for each slide. The two slides were then subsequently
averaged for statistical analysis. The CEP also was imaged three times per slide however
cellularity was not measured due to variability of the bone above or below the CEP which
varied and therefore would influence cellularity.
Slides stained for ABPR were imaged holistically using a Keyence NZ-X800
(Keyence Corporation; Osaka, Japan) at 100X total magnification and stitched together
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using the manufacturer-provided software. Discs were then compared between the Control
and Injury group to determine if there was any difference in staining intensity which would
reflect differences in ECM composition.
Modified FAST stain samples were imaged holistically using a Keyence NZ-X800
(Keyence Corporation; Osaka, Japan) at 100X total magnification and stitched together
with the provided software. Disc’s microarchitectural changes were then visually observed.
Additionally, a technique was created to determine the total distance of 5 IAF lamellae.
This was done by going 1mm into the OAF opposite of the Injury marking the first 5 full
lamellae. Once counted the distance was used to determine the overall distance over those
5 lamellae, as seen in Appendix A-1. This technique sought to quantify any AF inward
bulging that might occur in the lamella.
All statistical analysis was conducted at an alpha value of 0.05.

III. Results
H&E showed no distinct difference in the AF region between the Control and Injury
group. The NP region showed ECM difference as the Control group stained a darker purple
when exposed to hematoxylin for the same duration as the Injury group. Representative
images of H&E are shown in Figure 4.1.
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CHAPTER 5
Aim 3: Assessment of Seeded Scaffolds to Maintain Cell Viability and Disc
Microarchitecture

I. Statement of Purpose
Following the establishment of the Injury and Control group a third group using the
ABNP and AFRP was sought to be implemented in the bIVD organ culture model to assess
their potential benefits for modulating repair. In a short review, the ABNP is a
decellularized construct that mimics native NP tissue while support hMSCs viability, and
the AFRP is another decellularized scaffold that mimics native AF lamellae while not only
providing excellent puncture resistance but also supporting cell viability. Although these
constructs have had preliminary testing in vivo their overall effectiveness in IVD tissue
repair and regeneration is not yet fully determined. Furthermore, the implementation of
these scaffolds in an ex vivo environment will allow for better determination of surgical
techniques and determining potential future best practices for implementation.
It was hypothesized that using novel surgical techniques, the ABNP and AFRP
could be secured to a bIVD without cytotoxic reaction and preserve the microarchitecture
of the disc following a discectomy.

II. Methods and Materials
The bIVDs were isolated, injured, and cultured as previously described for the
Injury group. Following, two days in free swelling culture surgical repair using the ABNP
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and AFRP was performed. Both scaffolds were prepared by seeding 200,000 human
amniotic mesenchymal stromal cells (hAMSCs) from passage 4 or 5 on the scaffold. For
the ABNP, the scaffold was cut into 3 pieces and injection seeded in at least two locations
per scaffold piece resulting in at least 200,000 cells. The AFRP was seeded on one side
with 200,000 cells. The scaffolds were then transferred to a non-cell adherent 24 well plate
and incubated for 4 hours at 37oC with 20% and 5% relative CO2. Following cell
adherence, the scaffolds were ready for implementation.
First using sterile tweezers, the discectomy track was determined and ensured to be
clear of any obstruction. Then, two to three pieces of seeded ABNP were inserted and
pushed deep into the discectomy track where presumably the NP would reside. Next, using
Arthrex FiberWire 4-0 suture (Arthrex; Naples, FL) with curved diamond point tip, two
interrupted sutures parallel to the CEP were added, much like a modified jetting suture
technique.45 These two sutures would act to restore IAF tension while also forcing the
ABNP not to slip out of place from the NP. In cases where an ABNP might have slipped
out of the NP while applying the sutures, tweezers were used to reposition the ABNP prior
to tying the second suture with a surgeon’s knot. Lastly, the AFRP was added to the exterior
of the wound covering the 6mm OAF defect with the seeded hAMSCs side in direct contact
with the bIVD. The AFRP was secured with interrupted sutures using FiberWire 4-0 into
the adjacent OAF in all four corners of the patch. The surgically repaired bIVD was then
returned to a new specimen cup with pro-inflammatory media refreshed every 3 days just
as the Injury groups. These surgically repaired bIVDs as shown in Figure 5.1 are referred
to as the Repair group.
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CHAPTER 6
Current Limitations and Future Work

I. Summary Results
The bIVD model created within this work allowed for long-term and stable cell
viability culturing with and without the implementation of an aggressive discectomy. The
Injury group allowed for a controlled, reproducible discectomy-like injury to be induced
which subsequently showed key morphological differences relative to uninjured controls.
One key difference shown was the staining intensity of the NP region suggesting ECM
change or decomposition via H&E and ABPR. Another difference, though not statistically
significant was that the microarchitecture of the opposite IAF to the discectomy was shown
to bulge inwards suggesting microarchitectural deformation and destruction. To
characterize this style of degeneration, a replicable method of counting and analysis was
created as previously mentioned using 5 lamellae layer distances combined and recorded
for direct comparison between groups.
In addition to creating a stable free swelling Control and Injury, a seeded repair
using two novel scaffolds: the ABNP and AFRP, were able to be implemented into the
model following two days in culture. Scaffolds were seeded with hAMSCs before surgical
implementation, which subsequent imaging in the bIVD suggested high hAMSCs viability
around the injection sites even out to 30 days in culture without impairing bIVD cell
viability. Furthermore, at 30 days bIVDs from the Repair group showed that the ABNP
was nearly identical to its adjacent NP tissue in the H&E stain. Furthermore, the ABPR
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showed substantial similarity of the ABNP to the adjacent NP tissue while only slightly
lighter in color relative to the Control group’s NP. Lastly, the modified FAST stain showed
that the AFRP and ABNP were substantially like the OAF and NP of the Control tissue
suggesting similar ECM and microarchitecture. Additionally, these scaffolds were
observed to fill the void caused by the aggressive discectomy model and even were
suggested to reverse or counteract the inward bulging of the opposite AF.

II. Discussion
The objective of this study was to create a viable bIVD organ culture model that
allowed for histological characterization of an aggressive discectomy which could
subsequently be used to test the therapeutic effects of tissue engineered constructs. To
successfully create the aggressive discectomy model, the isolation and preparation of
bIVDs for culture had to be evaluated in an uninjured Control group. Cell viability in the
Control group boasted high (>70%) mean viability which remained statistically unchanged
and stable between 2, 14, and 30 days. This average viability is in coordination with
previous models64,66 at similar time points but also boasts prolonged stable viability as is
often difficult to maintain in bIVD organ culture.23 These results were further supported
even when an aggressive discectomy was performed. Although the viability was found
high (>70%), were significant trends and shifts between the two groups. While the Control
group seemed to maintain or slightly increase in cell viability at 30 days the Injury group
showed trends with decreasing viability in both the AF and NP. This gradual decrease in
viability at the 30 day time point resulted in significantly lower viability in the Injury AF
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(p = 0.017) relative to the Control AF which is indicative of IVDD.11,18 Therefore, the free
swelling model created boasted similar viability to other free swelling models while
potentially showing degenerative markers of IVDD through gradual decrease in cell
viability following aggressive discectomy and 30 days in culture.
The seeded Repair showed statistically decreased cell viability in the AF relative to
the Control at 14 days however was significantly unchanged from the Injury. The Repair’s
low viability in both the AF and NP seemed to recover at 30 days though no statistical
differences between time points was seen, but this was the reverse of what was seen in the
Injury group suggesting that the hAMSCs or implant might be causing regenerative trends
or changes as previous studies have seen in vitro bone marrow derived MSCs co-culture
with NP cells.53 One previous study in vivo has shown that no significant regenerative
effects of MSCs was observed until 106 MSCs were injected.73 Based on this previous
work, the 200,000 cells used per ABNP scaffold would potentially need to be increased to
increase their efficacy. Beyond determine the proper dosage for MSCs, another lingering
question that could be addressed in these culture models is the effectiveness of
preconditioned or pre-differentiated MSCs. While a lot of work is currently being
investigated for the best practice to differentiate MSCs to a discogenic phenotype,53 the
longevity of these precursor AF/NP cells remains largely unknown in long-term and
complex culture systems such as organ culture model. Although the full potential of MSCs
remains largely unknown, IVD organ cultures appear to be an excellent test ground for
studying their efficacy and proper concentration for therapeutic application.
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It is important to note that the ABNP filled the void caused by the aggressive
discectomy much like a recent novel geninpin-enhanced fibrin hydrogel did in a similar
model.63 Therefore, organ culture models with aggressive discectomies will be essential
for pre-screening new novel NP tissue engineered scaffolds to backfill any void caused by
the aggressive discectomy which might cause subsequent degeneration.2,44 Beyond NP
constructs, IVD organ culture models are paving the way for new novel methods to test
surgical fixation and annular repair. For example, in the work herein a modified “jetting
suture” technique alongside the AFRP was able to prevent re-herniation or extrusion of the
ABNP scaffolds much like a silk scaffold was.63 In order to help develop the next
generation of scaffolds for IVDH repair, organ culture models will need to become
standard test procedure to predetermine surgical implantation prior to in vivo studies.
Histological quantification of IVD organ cultures is yet to be standardized. Most
degenerative cultures seem to be quantified through the upregulation of inflammatory
markers or biochemically through quantification of the ECM in key regions such as the AF
and NP.10,22 This might be because histological grading scales partially rely on the
symmetry of the IVD,68 and thereby might not hold valid or applicable especially when a
discectomy like injury is induced. Therefore, within this work a method of determining
annular lamellae changes was created through measuring the distance of 5 IAF layers to
quantify bulging and distortion. Hopefully, this method can be implemented or added to
help visually quantify physical microarchitecture changes to help demonstrate
degeneration beyond the current methods.
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III. Current Limitations
General limitations of the general culture were the lack of mechanical loading
within the model, although initially planned the time and funding available did not allow
for mechanical loading. Ideally, the model would have a static load of 0.3-0.4 MPa added
for 8-12 hours during the day followed by a lower static load such as 0.1 MPa for the
remain duration of the day to more accurately resemble native IVD loading regimens.
Another limitation could be to include varying osmolarity of medias to explore the role of
hypo or hyper-osmolarity and potential subsequent roles of this on degeneration of the
IVD. Finally, the culture period could likely be increased out to 45 or 60 days to test its
effectiveness out to later time points.
Other limitations resided in sample size and statistical analysis. For most time
points and groups only 3 bIVDs were able to be allocated which resulted in weak or no
statistical significance in key trends that were seen such as the change in microarchitecture.
Furthermore, it made extrapolation of results challenging due to not knowing if the bIVD
variability played a larger role than potentially implicated. Larger sample size might have
helped discover if a subtle difference in variation in NP nuclei lacuna presence, which
sometimes were observed to disappear between groups; however, this was explicitly not
previously addressed as it might have been due to sectioning and tissue processing artifact
of the complex biphasic tissue. Representative images of this phenomenon can be seen in
Appendix B-1.
The surgical repair could be improved through the implementation of new methods
of AFRP securement. Since, IVD discectomy is an arthroscopic surgery the securement of
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the AFRP using surgical knots into the adjacent OAF might prove challenging.
Furthermore, since other studies have shown that needles could potentially cause
subsequent degeneration, the use of needle led suture might also. Furthermore, before
actual implementation of the AFRP and ABNP it might be beneficial to increase the
hAMSCs density in each scaffold up to ten-fold based on recent literature.73 One benefit
of the surgical model implemented was the modified jetting sutures; however, they were
shown to varying in depth and placement resulting in varied placement of the ABNP.
Therefore, this technique could be expanded open and optimized ensuring proper central
ABNP placement in the bIVD.
Other limitations surround the extrapolation of results. Since it was suggested that
potential GAGs leaching occurring in the Injury group in particular it might be beneficial
to collect CCM at certain time points for specialized arrays to tested for GAGs content.
Another key extrapolation of results that was limited was the cell viability imaging.
Although cell viability was able to be accurately measured an improved could be using 3D
confocal imaging to not only visual viability in a single cross-section but through a whole
tissue depth allowing for super accurate and holistic results.

IV. Future Work and Next Directions
To combat the limitations discovered and mentioned above there are a series of
steps that can be implemented to improve the culture of the bIVDs. First and foremost, the
study could be replicated with the same sample size thus doubling the current sample size
which will likely allow for statistical significance in many areas to be discovered.
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Furthermore, in this repeat study the addition of CCM aliquoting could be implemented to
potentially track any GAGs leaching or degradation into the CCM. At the time point of this
study the cell viability imaging could be replicated on half of the disc while the other half
could be cross validated with confocal imaging techniques.
The organ culture model in the future could also be used to determine how the cells
adapt to the free swelling environment. Once such mechanism could be to use a cytokine
array to track IL-6 in the CCM throughout each of the time points or media changes to see
if there is an increase in inflammation throughout the duration of the study. Since TNF-𝛼
and IL-1𝛽 were already introduced to the CCM, IL-6 or another cytokine would need to be
quantified to avoid confounding results. Alternatively, tissue could be recovered from the
samples at terminal time points and the cells could be isolated for genetic profiling through
reverse transcription quantitative polymerase chain reaction for key inflammatory markers
as previously conducted.29,34 Furthermore, within this experiment the phenotype of the NP
cells which is known to be prone to change and dedifferentiation in many culture models57
could be evaluated for genetic markers such as CA12, HIF-1a, FOX1, and PAX1li.15,27,72
These same markers could then be used on the ABNP tissue to determine if the hAMSCs
were differentiating into a NP cell type.
Another future direction could be the implementation of static culture in the model
or even collaboration with a lab that has previously derived a dynamic culture environment
strategy such as previously mentioned authors.65,66 To replicate this model under these
loading conditions the isolation of the bIVDs would need to be modified to allow for the
BEP to remain intact for proper fixation which might introduce new culture variation.
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Ultimately, although the culture has its limitations its low cost and easy replicability
allows for a novel bIVD model which is friendly to international usage. Although still early
in its development this model has already shown its effectiveness in characterization and
potential screening for next generation tissue engineering constructs.
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